XOMA Ltd.Berkeley, CA, United States (NASDAQ (GM): XOMA)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

XOMA Financial Statements

XOMA Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

XOMA Income Statement

  2008 2007 2006
Revenue ($ mil.) 68.0 84.3 29.5
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) (38.0) (0.7) (38.9)
Total Net Income ($ mil.) (45.2) (12.3) (51.8)
Diluted EPS (Net Income) (0.34) (0.10) (0.54)
More XOMA financial information

XOMA Quarterly Statements

  Quarter Ending Jun 09 Quarter Ending Mar 09 Quarter Ending Dec 08
Revenue ($ mil.) 9.7 39.7 36.9
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) (8.6) 13.8 --
Total Net Income ($ mil.) (10.2) 6.2 10.0
Diluted EPS (Net Income) (0.07) 0.04 0.08
More XOMA financial information

XOMA Stock Quote & Chart

11/06/09 15:59:58 EST • NASDAQ • 0.76 • Increased by +0.0220 • Increased by +2.9730 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

XOMA Financial Ratios

  Company Industry
Median
Market
Median1
Price/Sales Ratio 1.13 7.55 7.01
Price/Earnings Ratio (7.42) 93.46 25.51
Price/Book Ratio (6.84) 3.48 6.74
Price/Cash Flow Ratio (20.83) 41.49 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed XOMA Financial Ratios

XOMA Competitive Intelligence

Abbott Labs Amgen Pfizer
Annual Sales ($ mil.) 29,527.6 15,003.0 48,296.0
Employees 69,000 16,900 81,800
Market Cap ($ mil.) 79,660.8 55,536.4 136,859.3

Competitive Landscape

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy